It is in accordance with the finding that PI3K pathway activation promotes resistance of neuroblastoma to BET inhibition which was discovered by Iniguez et al. through genome-scale screening and multiomics analysis48. The gene discussed is PIK3CA; the disease is neuroblastoma.